KOD Kodiak Sciences Inc

Price (delayed)

$34.15

Market cap

$2.14B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.17

Enterprise value

$2.12B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 3

Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, Kodiak is focused on bringing new ...

Highlights
KOD's debt is down by 7% YoY and by 2% QoQ
The equity has declined by 29% since the previous quarter but it has increased by 3% year-on-year
The EPS has contracted by 15% YoY but it has grown by 3.5% from the previous quarter
Kodiak Sciences's quick ratio has decreased by 25% from the previous quarter and by 25% YoY
Kodiak Sciences's net income has decreased by 21% YoY

Key stats

What are the main financial stats of KOD

KOD stock price

How has the Kodiak Sciences stock price performed over time
Intraday
0.83%
1 week
-5.45%
1 month
-19.19%
1 year
760.2%
YTD
22.14%
QTD
-10.41%

Financial performance

How have Kodiak Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$235.09M
Net income
-$230.66M
Gross margin
N/A
Net margin
N/A
Kodiak Sciences's net income has decreased by 21% YoY
The operating income has contracted by 18% YoY

Price vs fundamentals

How does KOD's price correlate with its fundamentals

Growth

What is Kodiak Sciences's growth rate over time

Valuation

What is Kodiak Sciences stock price valuation
P/E
N/A
P/B
18.84
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has contracted by 15% YoY but it has grown by 3.5% from the previous quarter
The equity has declined by 29% since the previous quarter but it has increased by 3% year-on-year
The stock's P/B is 7% above its last 4 quarters average of 17.4

Efficiency

How efficient is Kodiak Sciences business performance
KOD's return on equity has dropped by 119% year-on-year
The ROA has plunged by 50% YoY
KOD's ROIC is down by 47% year-on-year and by 5% since the previous quarter

Dividends

What is KOD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KOD.

Financial health

How did Kodiak Sciences financials performed over time
The total assets is 58% greater than the total liabilities
KOD's current ratio is down by 25% since the previous quarter and by 23% year-on-year
Kodiak Sciences's quick ratio has decreased by 25% from the previous quarter and by 25% YoY
KOD's debt is 39% higher than its equity
KOD's debt to equity is up by 38% from the previous quarter but it is down by 10% YoY
The equity has declined by 29% since the previous quarter but it has increased by 3% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.